Showing results (1681-1690 of 2,149) with videos related to
Sort By:
Pageof 215
Journal of Ovarian Research|November 25, 2023
IFN-γ in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosisHui Zheng, Xiaolin Guan, Xin Meng, et al.Journal of Ovarian Research|November 23, 2023
Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy responseHua Yang, Xiangyu Gu, Rong Fan, et al.Journal of Ovarian Research|November 23, 2023
Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndromeSarad Pawar Naik Bukke, Bharghava Bhushan Rao Pathange, Srikanth Kumar Karumanchi, et al.Journal of Ovarian Research|September 18, 2023
The effect of letrozole overlapped with gonadotropin on IVF outcomes in women with DOR or aged over 40 years old with repeated cyclesXiaojia Li, Jingbo Chen, Yang Zhao, et al.Journal of Ovarian Research|August 3, 2023
Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in ChinaQingfang Li, Yimiao Sang, Qingqing Chen, et al.Journal of Ovarian Research|August 26, 2023
MicroRNA-338-3p helps regulate ovarian function by affecting granulosa cell function and early follicular developmentZiwen Xu, Tongwei Zhang, Jingyi Hu, et al.Journal of Ovarian Research|August 26, 2023
Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian CancerJiao Wang, Xiaocui Zhang, Fei Zheng, et al.Journal of Ovarian Research|August 16, 2023
Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysisWenjing Shao, Yuying Li, Yanli WangJournal of Ovarian Research|August 23, 2023
Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancerWei Huang, Yuliang Wu, Ning Luo, et al.Journal of Ovarian Research|August 22, 2023
The cost-effectiveness analysis of maintenance olaparib plus Bevacizumab in patients with advanced ovarian cancer: based on the final survival results from PAOLA-1 trialYouwen Zhu, Kun Liu, Hui Cao, et al.Pageof 215